Showing results (711-720 of 1,071) with videos related to

Sort By:
Pageof 108
Critical Care Medicine|January 19, 2011
Impaired endothelium-dependent vasodilatation is a novel predictor of mortality in intensive careMartin J Duffy, Brian A Mullan, Thelma R Craig, et al.
The Canadian Veterinary Journal = La Revue Veterinaire Canadienne|July 5, 2021
Evaluation of concurrent perineal hernia in adult male dogs presenting with nontraumatic, acquired inguinal herniasMandy L Wallace, Janet A Grimes, Daniel J Duffy, et al.
British Journal of Cancer|December 22, 2004
Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancerB Ryan, N O'Donovan, B Browne, et al.
The Analyst|November 10, 2011
Femtosecond lasers for mass spectrometry: proposed application to catalytic hydrogenation of butadieneOrla Kelly, Martin J Duffy, Raymond B King, et al.
International Journal of Cancer|December 20, 1996
High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinomaM P Chenard, L O'Siorain, S Shering, et al.
Heart, Lung & Circulation|August 31, 2015
Incidence, Predictors and Outcomes of Major Bleeding in Patients Following Percutaneous Coronary Interventions in AustraliaJohn Wlodarczyk, Andrew E Ajani, Dante Kemp, et al.
JACC. Cardiovascular Interventions|October 12, 2019
Risk-Adjusting Key Outcome Measures in a Clinical Quality PCI Registry: Development of a Highly Predictive Model Without the Need to Exclude High-Risk ConditionsMark Tacey, Diem T Dinh, Nick Andrianopoulos, et al.
American Journal of Hematology|September 26, 2003
Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vesselsRobert T Eberhardt, Lillian McMahon, Stephen J Duffy, et al.
Clinical Chemistry|April 18, 2015
Validation of new cancer biomarkers: a position statement from the European group on tumor markersMichael J Duffy, Catharine M Sturgeon, György Sölétormos, et al.
Investigational New Drugs|October 14, 2020
The novel low molecular weight MYC antagonist MYCMI-6 inhibits proliferation and induces apoptosis in breast cancer cellsDalal AlSultan, Emma Kavanagh, Shane O'Grady, et al.
Pageof 108